Investerare
Pressmeddelanden
-
Icke-regulatoriskt september 9, 2021Nanoform technology delivers successful results for Herantis CDNF drug candidate
-
Regulatoriskt augusti 27, 2021The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees